INTRODUCTION
============

Mushrooms are increasingly being consumed both in developed and under developed countries due to their nutritional and medicinal values. Today, edible mushrooms are considered as an important remedy for prevention and treatment of diseases ([@b1-tr-35-181]). Many researchers have reported that most edible mushrooms are therapeutic foods that exhibit numerous biological properties such as antibacterial, anticancer, antiviral activities and antioxidant properties ([@b2-tr-35-181],[@b3-tr-35-181]). Other researchers have also reported that edible mushrooms are rich sources of nutraceuticals ([@b4-tr-35-181],[@b5-tr-35-181]). There are about 200 species of mushroom and only 22 are cultivable, while others are not and *Lentinus squarrosulus* is among the cultivable mushroom species ([@b6-tr-35-181],[@b7-tr-35-181]). Mushrooms are reported to be more nutritive than vegetables and its nutritive content is comparable to meat, milk and egg ([@b6-tr-35-181],[@b8-tr-35-181]).

*Lentinus squarrosulus* is an edible wild or cultivated mushroom that belongs to the family Polyporaceae. Wild *L. squarrosulus* usually grow on decaying deciduous trees in tropical and sub-tropical rainforest such as Nigeria. *L. squarrosulus* is popularly known as 'Ero atakata or ata achicha puanya' in South-Eastern part of Nigeria. In traditional medicine, it is used in treatment of ulcer ([@b9-tr-35-181]), anaemia, infertility in both men and women ([@b10-tr-35-181]) and to lower the risk of chronic diseases ([@b11-tr-35-181]--[@b13-tr-35-181]). Venkatachalapathi and Paulsamy ([@b14-tr-35-181]) reported that *L. squarrosulus* is also utilized in the treatment of common diseases such as cough, fever, and fungal infections while Poompouang and Suksomtip ([@b15-tr-35-181]) stated that *L. squarrosulus* is highly appreciated in Thailand because of its curative and tonic characteristics.

Proximate analysis of *L. squarrosulus* has shown high content of protein ([@b9-tr-35-181]), minerals (potassium, magnesium, calcium, phosphorous and iron) ([@b16-tr-35-181]), thiamine, riboflavin, folic acid, and dietary fibres with low fat and caloric value ([@b9-tr-35-181]). The low fat and caloric content signifies that it could be useful as food or essential component of food for hyperlipidemic and diabetic patients ([@b17-tr-35-181]). Phytochemicals present in fruiting bodies, mycelia and spores include phenolic (gallic acid, catechin, isoquercetin, kaempferol), saponins, flavonoids, tannins, alkaloids, quinolones, terpenes, and anthraquinones ([@b18-tr-35-181],[@b19-tr-35-181]). Other primary metabolites present are peptides, steroids, benzoic derivatives, ascorbic acid, amino acids and oxalic acids ([@b20-tr-35-181],[@b21-tr-35-181]).

*L. squarrosulus* has been demonstrated to possess some antimicrobial properties against gram positive, gram negative and pathogenic bacteria ([@b22-tr-35-181],[@b23-tr-35-181]). The presence of both the secondary and primary metabolites including the antioxidants in *L. squarrosulus* has been indicated as the reason for its ability to modulate immunity ([@b13-tr-35-181],[@b24-tr-35-181]); regulate hypertension and hypercholestemia ([@b25-tr-35-181]), and its anti-oxidative and anticancer properties ([@b9-tr-35-181],[@b13-tr-35-181]). Interestingly, at present mushroom extracts including *L. squarrosulus* are commercially available as dietary supplement due to their immune modulation and anticancer activity ([@b26-tr-35-181],[@b27-tr-35-181]). Wild mushroom is preferred than artificially cultivated ones in many countries and has been shown to be more nutritious with high medicinal value compare to artificially cultivated ones ([@b28-tr-35-181],[@b29-tr-35-181]). When grown on heavily polluted environment, mushrooms also accumulate high level of hazardous heavy metals such as cadmium and mercury ([@b28-tr-35-181]). Previous studies by Omar *et al*. ([@b9-tr-35-181],[@b12-tr-35-181]) reported that *L. squarrosulus* is not toxic and stated that the LD~50~ is greater than 5 g/kg body weight. In both studies, they established that at the doses of 250 mg/kg and 500 mg/kg that the extract of *L. squarrosulus* did not cause any liver damage due to non-significant increase in the activity of liver biomarkers (AST, ALT and ALP) when compared to the control.

Although, there are numerous reports on nutritional constituents, anti-inflammatory, anticancer, anti-diabetic, anti-cholestamic, anti-ulcer and anti-oxidative properties of wild *L. squarrosulus*, little or no reports have been published on bioactive components and the toxicity of the aqueous extract. Therefore, this present study evaluates the bioactive components and also toxicity profile of aqueous extract of boiled wild dried *L. squarrosulus* in rats.

MATERIALS AND METHODS
=====================

Mushroom collection and authentication
--------------------------------------

Fresh wild *L. squarrosulus* was collected from its natural habitat in Isiala Ngwa South Local Government Area of Abia State, Nigeria in May 2016 and authenticated by a Mycologist at African Centre for Mushroom Research and Technology Innovation (ACMRTI) with herbarium reference number ACMBRTI00045.

Preparation of the extract
--------------------------

Fresh wild *L. squarrosulus* was destalked and washed with deionized water before sun drying for 7 days. After sun drying, *L. squarrosulus* was grinded to powder using electric blender. Exactly 300 g of the powdered *L. squarrosulus* were boiled for 30 min in 1 L distilled water. The boiled sample was allowed to cool at room temperature and then filtered using Whatman^®^ Grade No 1 filter paper (Fisher Scientific, Loughborough, UK). The filtrate (aqueous extract) was freeze-dried prior to usage. The extract was later reconstituted in distilled H~2~O to give the required doses of 500, 1,000, 1,500, 2,000 and 5,000 mg/kg body weight required for this study.

Gas chromatography-mass spectrometric (GC-MS) analysis
------------------------------------------------------

The aqueous extract of wild *L. squarrosulus* was subjected to GC-MS analysis. The analysis was conducted using Agilent 7890A-5975C GC-MS system. A HP5-column (30 m × 0.25 mm × 0.25 **μ**m), operating in electron impact mode at 70 eV was used. The carrier gas was ultra-pure helium at a flow rate of 1.0 mL/min and a linear velocity of 37 cm/s. The injector temperature was set at 250°C. The initial oven temperature was at 110°C which was programmed to increase to 280°C at the rate of 10°C/min with a hold time of 7 min at each increment. Injections of 0.5 **μ**L were made in the splitless mode with a split ratio of 10:1. The mass spectrometer was operated in the electron ionization mode at 70 eV. The bioactive compounds were identified by direct comparison of the retention time, mass spectral data and fragmentation pattern with those in the National Institute of Standards and Technology library.

Animal handling
---------------

Experimental procedures and animal handling were approved by the Abia State University, Research Ethical Clearance Committee (ABSU/REC/BMR/0013). Healthy rats weighing between 140 and 180 g were purchased from animal house of University of Nigeria Nsukka, Nigeria. The rats were transported to Department of Biochemistry, Abia State University, Nigeria and allowed to acclimatize to laboratory conditions for two weeks. The rats were kept under normal standard environmental conditions of temperature (25--28°C), humidity (35--60%) and 12 hr/12 hr light/darkness cycles. They were also fed *ad libitum* with standard rat feed and allowed free access to water. Ethical principles of World health Organization good laboratory practice regulations of 1998 and United States guidelines for experimental animals ([@b30-tr-35-181],[@b31-tr-35-181]) were strictly adhered throughout the study.

Acute toxicity test
-------------------

In accordance to the guideline of Organization for Economic Cooperation and Development (OECD) ([@b32-tr-35-181]) guideline 423 with little modifications, rats were randomly divided into 5 groups of 12 rats (6 males and 6 females). The male ([@b6-tr-35-181]) and female ([@b6-tr-35-181]) rats were kept in different cages for each group. Followed by oral administration of graded single dose of 500, 1,000, 2,000 and 5,000 mg/kg of aqueous extract of *L. squarrosulus* and the control group received 0 mg/kg of the *L. squarrosulus* extract. The rats were allowed free access to food and water *ad libitum* and monitored for a period of 24 hr post-treatment. Within and after the period of 24 hr, behavioural changes and signs of toxicity were assessed.

Sub-chronic toxicity study
--------------------------

According to the guidance of Organization for economic cooperation and development (OECD) ([@b33-tr-35-181]) guideline 407 with slight modifications, twenty four rats were randomly divided into 4 groups of 6 rats per group. The aqueous extract of *L. squarrosulus* were administered orally at doses of 500, 1,000, 1,500 mg/kg and the control group received 0 mg/kg of the *L. squarrosulus* extract daily for 14 days. The rats were allowed access to food and water *ad libitum* and weighed daily throughout the period of experiment.

Organ and blood sample collection
---------------------------------

At the end of the treatment with aqueous extract of *L. squarrosulus* (14th day), the rats were fasted overnight and sacrificed on the 15th day of the experiment. Blood samples were collected via cardiac puncture with the help of syringe and needle. The samples for biochemical tests were dispensed into heparinized containers while the samples for haematological analysis were dispensed into ethylenediaminetetraacetic acid (EDTA) containers. The liver, kidneys, heart, lungs and spleen were removed carefully by dissection and the weight of the organs was determined by weighing. Then the organs were fixed in 10% (v/v) formalin saline for histological studies.

The relative organ weights were calculated using the equation below:
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Haematological and biochemical analysis
---------------------------------------

Haemoglobin (Hb) level, packed cell volume (PCV), white blood cell (WBC) count, platelets and red blood cell (RBC) indices such as mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), mean corpuscular volume (MCV) were analysed using the methods described by Bain *et al* ([@b34-tr-35-181]). Standard ready-to-use kits from Randox Laboratory Ltd., Co. (Antrim, UK) were used to determine the concentration of liver enzymes (alkaline phosphatase (ALP), alanine aminotransferase (ALT) and aspartate aminotransferase (AST)) and renal function parameters (urea, creatinine, sodium, potassium, chloride and bicarbonate) spectrophotometrically. Other parameters determined spectrophotometrically using standard ready to use kits from Randox Laboratory Ltd., Co. include total cholesterol (TC), triglycerol (TAG), very low density lipoprotein cholesterol (VLDL-C), low density lipoprotein cholesterol (LDL-C), and high density lipoprotein cholesterol (HDL-C). All the biochemical analyses were performed strictly following manufacturer's instructions.

Histological studies
--------------------

The liver and kidney which were fixed in 10% formalin after the rats were sacrificed, they were processed routinely and embedded in paraffin wax. Then, the tissues were sectioned to obtain 5 **μ**m thickness, stained with haematoxylin and eosin following the method described by Fisher *et al* ([@b35-tr-35-181]). The processed sections were finally viewed using light microscope and images obtained.

Statistical analysis
--------------------

One-way analysis of variance (ANOVA) with the R^TM^ Statistic software package, version 3.0.3 (<https://cran.r-project.org/src/base/R-3/>) and excel package (Microsoft, Washington, DC, USA) were used for statistical analysis. Figures were generated using Graph pad prism version 5.0 Graph Pad Software (San Diego, CA, USA). Tukey test post-hoc was used to identify statistical differences among groups. A *p*-value of **≤** 0.05 was considered statistically significant.

RESULTS
=======

The GC-MS analysis of the aqueous extract of *L. squarrosulus* reveals the presence of 15 chemical compounds of which only six out of the 15 identified compounds have known pharmacological activities as shown in [Table 1](#t1-tr-35-181){ref-type="table"}. The six ([@b6-tr-35-181]) bioactive compounds with pharmacological activities are; 1-tetradecene, fumaric acid, monochloride, 6-ethyloct-3-yl ester, 9-eicosene, phytol, octahydropyrrolo\[1,2-a\]pyrazine, and 3-trifluoroacetoxypentadecane ([Table 2](#t2-tr-35-181){ref-type="table"}).

The rats were assessed for signs of abnormalities before and after acute treatment with varying dosages from 500 to 5,000 mg/kg of aqueous extract of *L. squarrosulus* after 24 hr and thereafter for 14 days. No death was observed in all the groups ([Table 3](#t3-tr-35-181){ref-type="table"}). No death or sign of toxicity was observed after sub-acute (14 days) administration 500, 1,000, 1,500 mg/kg body weight of aqueous extract of *L. squarrosulus*. There was also no significant difference (*p* \> 0.5) in percentage weight gain and weight of organs in all the groups compared to control ([Table 4](#t4-tr-35-181){ref-type="table"}, [Fig. 1](#f1-tr-35-181){ref-type="fig"}).

The result of haematological study as shown in [Table 5](#t5-tr-35-181){ref-type="table"} demonstrated a non-significant difference (*p* \> 0.5) in PVC, RBC, MCHC, MCH, MCV, WBC, lymphocytes and eosinophil. Significant differences (*p* \< 0.5) were observed in neutrophil, monocytes and platelets of rats treated with 500, 1,000, 1,500 mg/kg body weight of aqueous extract of *L. squarrosulus* groups compared to control.

In the renal function study, a significant (*p* \< 0.05) decrease in K^+^, Na^+^ and Cl^−^ were observed on the rats treated with aqueous extract of *L. squarrosulus* (1,000 and 1,500 mg/kg body weight) compared to control group while no changes were observed in urea, creatinine and HCO~3~^−^ compared to control ([Fig. 2](#f2-tr-35-181){ref-type="fig"}).

ALT and AST significantly increased in rats treated with aqueous extract of *L. squarrosulus* (500, 1,000 and 1,500 mg/kg body weight) compared to control. In addition, ALP showed no significant change (*p* \> 0.05) with values ranging from 75.33 ± 11.93 to 86.67 ± 1.53 U/L ([Fig. 3](#f3-tr-35-181){ref-type="fig"}).

Lipid profile analysis showed a significant (*p* \< 0.05) decrease in cholesterol, triglycerol and LDL-C in all the groups treated with aqueous extract of *L. squarrosulus* compared to control group. Whilst, HDL-C showed no significant (*p* \> 0.05) change compared to control group with value ranging from 0.95--1.38 mMol/L ([Fig. 4](#f4-tr-35-181){ref-type="fig"}). The histological studies of the rat's liver and kidney showed no observable danger or changes as shown in ([Fig. 5](#f5-tr-35-181){ref-type="fig"}, [6](#f6-tr-35-181){ref-type="fig"}).

DISCUSSION
==========

The GC-MS analysis of the aqueous extract of *L. squarrosulus* revealed six bioactive compounds with pharmacological activities; 1-tetradecene has anti-tuberculosis activity ([@b36-tr-35-181]). Fumaric acid, monochloride, 6-ethyloct-3-yl ester, is used for treatment of psoriasis, phytol has antinociceptive and antioxidant effects ([@b37-tr-35-181]), octahydropyrrolo\[1,2-a\]pyrazine, has antioxidant property ([@b38-tr-35-181]) and 3-trifluoroacetoxypentadecane exhibits anti-nephrotoxic and antioxidant properties ([@b39-tr-35-181]) ([Table 2](#t2-tr-35-181){ref-type="table"}). Omar *et al*. ([@b12-tr-35-181]) reported that extract of *L. squarrosulus* has antioxidant properties, this may be due to the presence of phytol, octahydropyr-rolo\[1,2-a\]pyrazine, and 3-trifluoroacetoxypentadecane in the extract. The alcoholic extract of *L. squarrosulus* exhibits antimicrobial activity against the gram positive and gram negative microorganisms and antifungal activity comparable to antifungal drug like ketoconazole ([@b15-tr-35-181],[@b23-tr-35-181]). This antimicrobial activity may be because of the presence of 9-Eicosene in the extract ([@b40-tr-35-181]).

The acute toxicity study of aqueous extract of *L. squarrosulus* (500, 1,000, 2,000 and 5,000 mg/kg body weight) demonstrated no mortality, behavioural changes or toxicity signs. The administration of aqueous extract of *L. squarrosulus* up to 5,000 mg/kg body weight via oral route did not kill or cause the death of 50% of the rats. This is an indication that the LD~50~ of *L. squarrosulus* is greater than 5,000 mg/kg. According to Organization for economic cooperation and development (OECD) ([@b32-tr-35-181]), *L. squarrosulus* extract could be assigned as class 5 and thus considered as safe and non-toxic because in acute toxicity test, LD~50~ above 5,000 mg/kg is considered as non-toxic substance.

In sub-acute toxicity study, Wistar rats revealed no significant difference in body weight ([Table 4](#t4-tr-35-181){ref-type="table"}, thus no adverse effect in body weight following oral administration of aqueous extract of *L. squarrosulus* (500, 1,000, 1,500 mg/kg body weight) for 14 days. Changes in body weight and organ weight are often employed in assessing the possible harmful effect of potentially toxic chemicals and pharmaceutical substances ([@b41-tr-35-181]). All the rats in each group demonstrated optimal weight increase across.

Bone marrow is a known organ for haematopoietic processes and a target organ for toxic compound ([@b42-tr-35-181]). Blood is very pivotal in physiological, nutritional and pathological status of vertebrates and its assessment for toxicity is very essential. Haematological parameters are very sensitive and are useful for predicting the toxicological and pathological effect of potentially toxic substances in human and animals ([@b41-tr-35-181],[@b42-tr-35-181]). Although, there were significant differences (*p* \< 0.05) in neutrophil, monocyte and platelets, the obtained result of haematological parameters ([Table 5](#t5-tr-35-181){ref-type="table"}) were within the standard acceptable reference range ([@b43-tr-35-181],[@b44-tr-35-181]), for all the parameters suggesting that aqueous extract of *L. squarrosulus* had no negative effect on the bone marrow and immune system in all the studied dosage.

Data from serum biochemical parameters are usually used to assess the impact of toxic substances in the organs such as liver and kidney ([@b41-tr-35-181]). Cellular damage, tissue necrosis and cardiovascular diseases lead to increase in AST and ALT in the serum ([@b45-tr-35-181],[@b46-tr-35-181]). The ALP is often used to assess plasma membrane integrity and its high level in serum is an indication of plasma membrane damages. High level of ALP is usually observed in liver damage, myocardial infarction and cancer ([@b45-tr-35-181]). Both AST and ALT are markers of integrity and function of liver and heart and are released into the blood from damaged liver. In this study, there were no detrimental effects observed in ALP. The liver biomarkers (AST and ALT) were elevated (*p* \< 0.05) after administration of aqueous extract *L. squarrosulus* for 14 days but these changes were within the standard acceptable normal laboratory reference range ([@b44-tr-35-181]). Additionally, no lesions or pathological changes were observed in the histopathology of the liver, which is an indication that the liver was not deleteriously impaired ([Fig. 6](#f6-tr-35-181){ref-type="fig"}). This may be due to nontoxic effect of the bioactive compounds to the rats ([@b47-tr-35-181]). However, the observable significant increase in AST and ALT is an indication that higher doses greater than 1,500 mg/kg body weight may cause liver damage.

Increase in serum level of creatinine, urea and electrolytes such as sodium, chloride, bicarbonate, potassium and inorganic phosphate has been shown as a reliable indicator of renal malfunction ([@b41-tr-35-181]). This study demonstrated non-significant difference (*p* \> 0.05) in urea, creatinine and electrolytes except group administered with 500 mg/kg body weight including potassium and sodium ion which were slightly lower but are still within the standard reference range for rat experiments ([@b43-tr-35-181]). Hence, administration of aqueous extract *L. squarrosulus* (500, 1,000 and 1,500 mg/kg body weight) has no adverse effect on the renal function of the rats. The histological study of the kidney did not reveal any adverse effect on the microscopic changes or morphology of the kidney which supports the non-toxic effect of *L. squarrosulus* on kidney ([Fig. 5](#f5-tr-35-181){ref-type="fig"}).

Total cholesterol, triglycerides and LDL-C were decreased significantly (*p* \< 0.05) compared to the control group with group administered with 1,500 mg/kg body weight showing more than 50% decrease. The result corroborates with the findings of Kanagasabapathy *et al*. ([@b48-tr-35-181]) who reported that *Pleurotus sajor-caju* (Fr.) Singer mushroom decreased serum total cholesterol and LDL-C level suggesting that *L. squarrosulus* may have the potential to regulate hyperlipidaemia. However, non dose dependent increase in triglyceride was observed in rats that received 1,000 mg/kg extract when compared to the rats that received 500 and 1,500 mg/kg. This increase may not be treatment-related.

In conclusion, *L. squarrosulus* is non-toxic and could be used as a source of nutrients and in ethnomedicine without any detrimental effect at the tested doses. This study also established that there were dose-dependent significant increase in the liver biomarkers (AST and ALT) suggesting that increase in doses higher than 1,500 mg/kg may cause liver damage.

In this study, we recommend that the expected consumption of *L. squarrosulus* per individual in a normal meal should not exceed 1,500 mg/kg body weight; this recommendation is based on the dose-dependent significant increase observed in the liver biomarkers (AST and ALT).
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![Effect of aqueous dry extract of *L. squarrosulus* on the organ weight of Wistar rats. Values represent the mean ± SD for n = 6. Bars in the same group bearing the same letter of the alphabet (a) are not significantly different (*p* \> 0.05). Rats were administered with aqueous dry extract of *L. squarrosulus* (500, 1,000 and 1,500 mg/kg body weight) for 14 days then, sacrifice and the organ weight measured.](tr-35-181f1){#f1-tr-35-181}

![Effect of aqueous dry extract of *L. squarrosulus* on renal function of Wistar rats. Values represent the mean±SD for n=6. Bars in the same group bearing the same letter of the alphabet (a, b) are not significantly different (*p*\>0.05). Rats were administered with aqueous dry extract of *L. squarrosulus* (500, 1,000 and 1,500mg/kg body weight) for 14 days then, sacrifice and the renal function parameters measured spectrophotometrically.](tr-35-181f2){#f2-tr-35-181}

![Effect of aqueous dry extract of *L. squarrosulus* on hepatic enzymes of Wistar rats. Values represent the mean ± SD for n = 6. Bars in the same group bearing the same letter of the alphabet (a, b, c, d) are not significantly different from each other (*p* \> 0.05). Rats were administered with aqueous extract of *L. squarrosulus* (500, 1,000 and 1,500 mg/kg body weight) for 14 days then, sacrifice and the liver enzymes measured spectrophotometrically.](tr-35-181f3){#f3-tr-35-181}

![Effect of aqueous dry extract of *L. squarrosulus* on the lipid profile of Wistar rats. Values represent the mean ± SD for n = 6. Bars in the same group bearing the same letter of the alphabet (a, b, c, d) are not significantly different (*p*\>0.05). Rats were administered with aqueous dry extract of *L. squarrosulus* (500, 1,000 and 1,500mg/kg body weight) for 14 days then, sacrifice and the lipid profile determined spectrophotometrically.](tr-35-181f4){#f4-tr-35-181}

![Micrographs of the kidney sections obtained from untreated (control) and treated Wistar rats with various doses of aqueous dry extract of *L. squarrosulus*. Haematoxylin and eosin staining (H&E), Magnification (40×). (A), control (B), Wistar rats treated with 500mg/kg aqueous dry extract of *L. squarrosulus* (C), Wistar rats treated with 1,000mg/kg aqueous dry extract of (D), Wistar rats treated with 1,500mg/kg extract of *L. squarrosulus*.](tr-35-181f5){#f5-tr-35-181}

![Micrographs of the liver sections obtained from untreated (control) and treated Wistar rats with various doses of aqueous dry extract of *L. squarrosulus*. Haematoxylin and eosin staining (H&E), Magnification (40×). (A), control (B), Wistar rats treated with 500mg/kg aqueous dry extract of *L. squarrosulus* (C), Wistar rats treated with 1,000mg/kg extract of *L. squarrosulus* (D), wistar rats treated with 1,500mg/kg extract of *L. squarrosulus*.](tr-35-181f6){#f6-tr-35-181}

###### 

GC-MS spectral analysis of aqueous extract of *Lentinus squarrosulus*

  RT (min)   Name of the compound                                 Molecular formula     Molecular weight   Peak area %
  ---------- ---------------------------------------------------- --------------------- ------------------ -------------
  9.430      1-Tetradecene                                        C~14~H~28~            196                18.46
  9.796      Fumaric acid, monochloride, 6-ethyloct-3-yl ester    C~14~H~23~ClO~3~      274                1.96
  10.060     1-Buten-3-yne, 1-chloro−, (Z)−                       C~4~H~3~Cl            86                 1.27
  12.354     1-Buten-3-yne, 1-chloro-, (Z)-                       C~4~H~3~Cl            86                 1.23
  12.480     9-Eicosene, (E)-                                     C~20~H~40~            280                28.20
  12.778     Cyclopentanone, 2-(1-methylpropyl)                   C~9~H~16~O            140                2.76
  13.001     Acetic acid, dichloro-                               C~2~H~2~Cl~2~O~2~     128                3.00
  13.464     Phytol                                               C~20~H~40~O           296                1.28
  13.533     Cetene                                               C~16~H~32~            224                23.05
  13.619     1-Buten-3-yne, 2-chloro-                             C~4~H~3~Cl            84                 1.67
  13.733     Octahydropyrrolo\[1,2-a\]pyrazine                    C~7~H~14~N~2~         126                2.68
  13.899     3-Trifluoroacetoxypentadecane                        C~17~H~31~F~3~O~2~    324                2.24
  15.936     17-Pentatriacontene                                  C~35~H~70~            490                3.49
  16.256     Carbonic acid, tridecyl 2,2,2-trichloroethyl ester   C~16~H~29~Cl~3~O~3~   374                6.18
  16.548     Bromoacetic acid, pentadecyl ester                   C~17~H~33~BrO~2~      348                2.52

###### 

Structural and pharmacological potentials of major bioactive compounds present in aqueous extract of *Lentinus squarrosulus*

  Compound                                           Structure   Medicinal uses
  -------------------------------------------------- ----------- ----------------------------------------------------------------
  1-Tetradecene                                                  Anti-tuberculosis activity ([@b36-tr-35-181])
  Fumaric acid, monochlorid, 6-ethyloct-3-yl ester               Treatment of psoriasis ([@b37-tr-35-181])
  9-Eicosene                                                     Antimicrobial and cytotoxic properties ([@b40-tr-35-181])
  Phytol                                                         Antinociceptive and antioxidant effect ([@b37-tr-35-181])
  Octahydropyrrolo\[1,2-a\]pyrazine                              Antioxidant activity ([@b38-tr-35-181])
  3-Trifluoroacetoxypentadecane F                                Anti-nephrotoxic and antioxidant activities ([@b39-tr-35-181])

###### 

Acute (oral) toxicity of aqueous dry extract of *L. squarrosulus* mushroom to albino rats after 24 hr of administration

  Group   Dose (mg/kg)      D/T    Signs of toxicity
  ------- ----------------- ------ -------------------
  A       0.25 mL (H~2~O)   0/12   No toxic effects
  B       500               0/12   No toxic effects
  C       1000              0/12   No toxic effects
  D       2000              0/12   No toxic effects
  E       5000              0/12   No toxic effects

D/T: Number of albino rat deaths/Total number of albino rats used.

###### 

Effect of aqueous dry extract of *L. squarrosulus* on the body weight of rats after 14 days of administration

  Parameters         Dose (mg/kg)                                       
  ------------------ ---------------- ---------------- ---------------- ----------------
  Weight at day 0    144.00 ± 17.39   155.80 ± 16.45   166.00 ± 14.61   146.40 ± 14.61
  Weight at day 14   155.60 ± 24.10   166.00 ± 16.14   179.60 ± 16.44   163.20 ± 11.45
  Weight gain (g)    11.60            10.20            13.60            16.80
  Weight gain (%)    7.46             6.14             7.57             10.29

Values represent the mean ± SD for n = 6.

###### 

Effect of aqueous dry extract of *L. squarrosulus* on haematological parameters of Wistar rats

  Parameters             Dose (mg/kg)                                                  
  ---------------------- ------------------- -------------------- -------------------- -------------------
  PCV (%)                49.67 ± 0.58^a^     53.33 ± 0.58^a^      52.33 ± 6.03^a^      52.00 ± 2.65^a^
  Hb (g/dL)              14.40 ± 0.52^a^     14.07 ± 0.29^a^      14.00 ± 1.45^a^      14.33 ± 0.57^a^
  RBC (× 10^12^/L)       7.94 ± 0.18^a^      8.03 ± 0.13^a^       8.41 ± 1.13^a^       8.09 ± 0.41^a^
  MCV(fL)                64.40 ± 1.57^a^     64.70 ± 0.89^a^      62.23 ± 1.69^a^      64.07 ± 0.40^a^
  MCH (pg)               18.13 ± 0.23^a^     17.50 ± 0.17^a^      16.70 ± 0.82^a^      17.73 ± 0.45^a^
  MCHC (g/dL)            28.20 ± 0.53^a^     27.10 ± 0.56^a^      26.83 ± 0.61^a^      27.67 ± 0.64^a^
  WBC (× 10^9^/L)        12.93 ± 6.64^a^     10.27 ± 1.82^a^      12.50 ± 1.32^a^      12.23 ± 3.41^a^
  Neutrophil (%)         3.33 ± 0.58^a^      7.33 ± 3.21^b^       10.00 ± 2.00^c^      7.33 ± 0.58^b^
  Lymphocyte (%)         86.33 ± 2.31^a^     83.33 ± 6.66^a^      82.00 ± 2.00^a^      81.67 ± 4.51^a^
  Eosinophil (%)         2.33 ± 1.15^a^      2.67 ± 0.58^a^       3.67 ± 1.53^a^       2.67 ± 1.15^a^
  Basophil (%)           1.00 ± 0.00^a^      1.67 ± 1.15^a^       1.00 ± 0.00^a^       1.67 ± 1.15^a^
  Monocytes (%)          7.00 ± 1.00^b^      5.00 ± 2.00^b^       3.33 ± 1.53^a^       6.67 ± 3.06^b^
  Platelet (× 10^9^/L)   784.33 ± 54.01^a^   900.33 ± 122.17^c^   816.67 ± 123.66^b^   936.00 ± 47.70^c^

Values represent the mean ± SD for n = 6. Values in the same row bearing the same letter of the alphabet (a, b, c) are not significantly different (*p* \> 0.05). PVC, packed cell volume; Hb, Hemoglobin; RBC, red blood cell; MCV, mean corpuscular volume; MCH, mean corpuscular haemoglobin; MCHC, mean corpuscular hemoglobin concentration; WBC, white blood cell (WBC).
